Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transmucosal Effentora for pre-emptive procedural pain in opioid-tolerant cancer patients
2012-005032-29Phase 2Active
- Sponsor
- Association Bigorre Douleurs
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fentanyl in cancer pain and procedural pain, sponsored by Association Bigorre Douleurs. Primary endpoint: Primary efficacy endpoint. Started Sep 2015; status: active.
02
Drugs
fentanyl
03
Conditions
cancer painprocedural pain
Beyond the preview
Go deeper on 2012-005032-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005032-29.